Natural Killer Cells Therapeutics Market Trends & Forecast 2032

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Natural Killer Cells Therapeutics Market, 2024-2032 (USD Billion)
  • 2.2. Natural Killer Cells Therapeutics Market: Snapshot
• Chapter 3. Natural Killer Cells Therapeutics Market - Industry Analysis
  • 3.1. Natural Killer Cells Therapeutics Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Driver 1
    • 3.2.2. Driver 2
  • 3.3. Restraints
    • 3.3.1. Restraint 1
    • 3.3.2. Restraint 2
  • 3.4. Opportunity
    • 3.4.1. Government funding and support
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis By Product
    • 3.6.2. Market attractiveness analysis By Application
    • 3.6.3. Market attractiveness analysis By End-User
    • 3.6.4. Market attractiveness analysis By Region
• Chapter 4. Natural Killer Cells Therapeutics Market- Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Natural Killer Cells Therapeutics Market: company market share, 2024
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Product launches
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Natural Killer Cells Therapeutics Market - Therapeutics Analysis
  • 5.1. Global Natural Killer Cells Therapeutics Market overview: By Therapeutics
    • 5.1.1. Global Natural Killer Cells Therapeutics Market share, By Product,2024 and 2032
  • 5.2. NK Cell Directed Antibodies
    • 5.2.1. Global Natural Killer Cells Therapeutics Market By NK Cell Directed Antibodies, 2024-2032 (USD Billion)
  • 5.3. NK Cell Therapies
    • 5.3.1. Global Natural Killer Cells Therapeutics Market By NK Cell Therapies, 2024-2032 (USD Billion)
• Chapter 6. Global Natural Killer Cells Therapeutics Market -Application Analysis
  • 6.1. Global Natural Killer Cells Therapeutics Market overview: By Application
    • 6.1.1. Global Natural Killer Cells Therapeutics Market share, By Application, 2024 and 2032
  • 6.2. Immunoproliferative Disorders
    • 6.2.1. Global Natural Killer Cells Therapeutics Market By Immunoproliferative Disorders, 2024-2032 (USD Billion)
  • 6.3. Gastrointestinal Diseases
    • 6.3.1. Global Natural Killer Cells Therapeutics Market By Gastrointestinal Diseases, 2024-2032 (USD Billion)
  • 6.4. Cancer
    • 6.4.1. Global Natural Killer Cells Therapeutics Market By Cancer, 2024-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Natural Killer Cells Therapeutics Market By Other Applications, 2024-2032 (USD Billion)
• Chapter 7. Global Natural Killer Cells Therapeutics Market -End-User Analysis
  • 7.1. Global Natural Killer Cells Therapeutics Market overview: By End-User
    • 7.1.1. Global Natural Killer Cells Therapeutics Marketshare, By End-User, 2024 and 2032
  • 7.2. Hospitals
    • 7.2.1. Global Natural Killer Cells Therapeutics Market By Hospitals, 2024-2032 (USD Billion)
  • 7.3. Research Centers & Institutes
    • 7.3.1. Global Natural Killer Cells Therapeutics Market By Research Centers & Institutes, 2024-2032 (USD Billion)
  • 7.4. Others
    • 7.4.1. Global Natural Killer Cells Therapeutics Market By others, 2024-2032 (USD Billion)
• Chapter 8. Global Natural Killer Cells Therapeutics Market - Regional Analysis
  • 8.1. Global Natural Killer Cells Therapeutics Market overview: By Region
    • 8.1.1. Global Natural Killer Cells Therapeutics Marketshare, By Region, 2024 and 2032
  • 8.2. North America
    • 8.2.1. North America Natural Killer Cells Therapeutics Market, 2024-2032 (USD Billion)
    • 8.2.2. North America Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
    • 8.2.3. North America Natural Killer Cells Therapeutics Marketrevenue, By Application, 2024-2032 (USD Billion)
    • 8.2.4. North America Natural Killer Cells Therapeutics Market revenue, By End-User, 2024-2032 (USD Billion)
    • 8.2.5. The U.S.
      • 8.2.5.1. The U.S.Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
      • 8.2.5.2. The U.S.Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
      • 8.2.5.3. The U.S.Natural Killer Cells Therapeutics Market revenue, By End-User, 2024-2032 (USD Billion)
    • 8.2.6. Rest of North America
      • 8.2.6.1. Rest of North America Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
      • 8.2.6.2. Rest of North America Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
      • 8.2.6.3. Rest of North America Natural Killer Cells Therapeutics Market revenue, By End-User, 2024-2032 (USD Billion)
  • 8.3. Europe
    • 8.3.1. EuropeNatural Killer Cells Therapeutics Market2024-2032 (USD Billion)
    • 8.3.2. Europe Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
    • 8.3.3. Europe Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
    • 8.3.4. Europe Natural Killer Cells Therapeutics Marketrevenue, By End-User, 2024-2032 (USD Billion)
    • 8.3.5. UK
      • 8.3.5.1. U.K.Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
      • 8.3.5.2. U.K.Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
      • 8.3.5.3. U.K. Natural Killer Cells Therapeutics Marketrevenue, By End-User, 2024-2032 (USD Billion)
    • 8.3.6. France
      • 8.3.6.1. France Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
      • 8.3.6.2. France Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
      • 8.3.6.3. France Natural Killer Cells Therapeutics Market revenue, By End-User, 2024-2032 (USD Billion)
    • 8.3.7. Germany
      • 8.3.7.1. Germany Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
      • 8.3.7.2. Germany Natural Killer Cells Therapeutics Marketrevenue, By Application, 2024-2032 (USD Billion)
      • 8.3.7.3. Germany Natural Killer Cells Therapeutics Market revenue, By End-User, 2024-2032 (USD Billion)
    • 8.3.8. Rest of Europe
      • 8.3.8.1. Rest of EuropeNatural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
      • 8.3.8.2. Rest of EuropeNatural Killer Cells Therapeutics Marketrevenue, By Application, 2024-2032 (USD Billion)
      • 8.3.8.3. Rest of Europe Natural Killer Cells Therapeutics Market revenue, By End-User, 2024-2032 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Natural Killer Cells Therapeutics Market, 2024-2032 (USD Billion)
    • 8.4.2. Asia Pacific Natural Killer Cells Therapeutics Marketrevenue, By Product,2024-2032 (USD Billion)
    • 8.4.3. Asia Pacific Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
    • 8.4.4. Asia Pacific Natural Killer Cells Therapeutics Marketrevenue, By End-User, 2024-2032 (USD Billion)
    • 8.4.5. China
      • 8.4.5.1. China Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
      • 8.4.5.2. China Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
      • 8.4.5.3. China Natural Killer Cells Therapeutics Marketrevenue, By End-User, 2024-2032 (USD Billion)
    • 8.4.6. Japan
      • 8.4.6.1. Japan Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
      • 8.4.6.2. Japan Natural Killer Cells Therapeutics Marketrevenue, By Application, 2024-2032 (USD Billion)
      • 8.4.6.3. Japan Natural Killer Cells Therapeutics Market revenue, By End-User, 2024-2032 (USD Billion)
    • 8.4.7. India
      • 8.4.7.1. India Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
      • 8.4.7.2. India Natural Killer Cells Therapeutics Marketrevenue, By Application, 2024-2032 (USD Billion)
      • 8.4.7.3. India Natural Killer Cells Therapeutics Market revenue, By End-User, 2024-2032 (USD Billion)
    • 8.4.8. Rest of Asia Pacific
      • 8.4.8.1. Rest of Asia Pacific Natural Killer Cells Therapeutics Marketrevenue, By Product,2024-2032 (USD Billion)
      • 8.4.8.2. Rest of Asia Pacific Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
      • 8.4.8.3. Rest of Asia Pacific Natural Killer Cells Therapeutics Market revenue, By End-User, 2024-2032 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America Natural Killer Cells Therapeutics Market, 2024-2032 (USD Billion)
    • 8.5.2. Latin America Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
    • 8.5.3. Latin America Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
    • 8.5.4. Latin America Natural Killer Cells Therapeutics Market revenue, By End-User, 2024-2032 (USD Billion)
    • 8.5.5. Brazil
      • 8.5.5.1. Brazil Natural Killer Cells Therapeutics Marketrevenue, By Product,2024-2032 (USD Billion)
      • 8.5.5.2. Brazil Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
      • 8.5.5.3. Brazil Natural Killer Cells Therapeutics Market revenue, By End-User, 2024-2032 (USD Billion)
    • 8.5.6. Rest of LatinAmerica
      • 8.5.6.1. Rest of LatinAmerica Natural Killer Cells Therapeutics Market revenue, By Product,2024-2032 (USD Billion)
      • 8.5.6.2. Rest of LatinAmerica Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
      • 8.5.6.3. Rest of Latin America Natural Killer Cells Therapeutics Marketrevenue, By End-User, 2024-2032 (USD Billion)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa Natural Killer Cells Therapeutics Market, 2024-2032 (USD Billion)
    • 8.6.2. The Middle East and Africa Natural Killer Cells Therapeutics Marketrevenue, By Product,2024-2032 (USD Billion)
    • 8.6.3. The Middle East and Africa Natural Killer Cells Therapeutics Market revenue, By Application, 2024-2032 (USD Billion)
    • 8.6.4. The Middle East and Africa Natural Killer Cells Therapeutics Marketrevenue, By End-User, 2024-2032 (USD Billion)
• Chapter 9. Company Profiles
  • 9.1. NKT Therapeutics Inc.
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product Portfolio
    • 9.1.4. Business Strategy
    • 9.1.5. Recent Developments
  • 9.2. Nkarta Therapeutics, Inc
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategy
    • 9.2.5. Recent Developments
  • 9.3. Nantkwest Inc.
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategy
    • 9.3.5. Recent Developments
  • 9.4. Innate Pharma S.A.
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategy
    • 9.4.5. Recent Developments
  • 9.5. Glycostem Therapeutics BV
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategy
    • 9.5.5. Recent Development
  • 9.6. Fortress Biotech
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategy
    • 9.6.5. Recent Development
  • 9.7. Fate Therapeutics
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product Portfolio
    • 9.7.4. Business Strategy
    • 9.7.5. Recent Development
  • 9.8. Company08
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategy
    • 9.8.5. Recent Development
  • 9.9. Celgene Corporation
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategy
    • 9.9.5. Recent Development
  • 9.10. Affimed N.V.
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product Portfolio
    • 9.10.4. Business Strategy
    • 9.10.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global natural killer cells therapeutics market, 2024-2032 (USD Billion)
4. Porter’s five forces analysis: natural killer cells therapeutics market
5. Global natural killer cells therapeutics market attractiveness, by therapeutics
6. Global natural killer cells therapeutics market attractiveness, by application
7. Global natural killer cells therapeutics market attractiveness, by end user
8. Global natural killer cells therapeutics market revenue share, by therapeutics, 2024 and 2032
9. Global natural killer cells therapeutics market by NK Cell Directed Antibodies, 2024-2032 (USD Billion)
10. Global natural killer cells therapeutics market by NK Cell Therapies, 2024-2032 (USD Billion)
11. Global natural killer cells therapeutics market revenue share, by application, 2024 and 2032
12. Global natural killer cells therapeutics market by Immunoproliferative Disorders, 2024-2032 (USD Billion)
13. Global natural killer cells therapeutics market by Gastrointestinal Diseases, 2024-2032 (USD Billion)
14. Global natural killer cells therapeutics market by Cancer, 2024-2032 (USD Billion)
15. Global natural killer cells therapeutics market by Other Applications, 2024-2032 (USD Billion)
16. Global natural killer cells therapeutics market revenue share, by end user, 2024 and 2032
17. Global natural killer cells therapeutics market by Hospitals, 2024-2032 (USD Billion)
18. Global natural killer cells therapeutics market by Research Centers & Institutes, 2024-2032 (USD Billion)
19. Global natural killer cells therapeutics market by Other End Users, 2024-2032 (USD Billion)
20. Global natural killer cells therapeutics market revenue share, by region, 2024 & 2032
21. North America natural killer cells therapeutics market, 2024-2032 (USD Billion)
22. Europe natural killer cells therapeutics market, 2024-2032 (USD Billion)
23. Asia Pacific natural killer cells therapeutics market, 2024-2032 (USD Billion)
24. Latin America natural killer cells therapeutics market, 2024-2032 (USD Billion)
25. Middle East & Africa natural killer cells therapeutics market, 2024-2032 (USD Billion)

Table Of Tables

List of Tables

1. Global natural killer cells therapeutics market: snapshot
2. Drivers for natural killer cells therapeutics market: impact analysis
3. Restraints for natural killer cells therapeutics market: impact analysis
4. North America natural killer cells therapeutics market revenue, by country, 2024-2032 (USD Billion)
5. North America natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
6. North America natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
7. North America natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
8. The U.S. natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
9. The U.S. natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
10. The U.S. natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
11. Rest of North America natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
12. Rest of North America natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
13. Rest of North America natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
14. Europe natural killer cells therapeutics market revenue, by country, 2024-2032 (USD Billion)
15. Europe natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
16. Europe natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
17. Europe natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
18. U.K. natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
19. U.K. natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
20. U.K. natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
21. France natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
22. France natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
23. France natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
24. Germany natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
25. Germany natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
26. Germany natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
27. Rest of Europe natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
28. Rest of Europe natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
29. Rest of Europe natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
30. Asia Pacific natural killer cells therapeutics market revenue, by country, 2024-2032 (USD Billion)
31. Asia Pacific natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
32. Asia Pacific natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
33. Asia Pacific natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
34. China natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
35. China natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
36. China natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
37. Japan natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
38. Japan natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
39. Japan natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
40. India natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
41. India natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
42. India natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
43. Rest of Asia Pacific natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
44. Rest of Asia Pacific natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
45. Rest of Asia Pacific natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
46. Latin America natural killer cells therapeutics market revenue, by country, 2024-2032 (USD Billion)
47. Latin America natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
48. Latin America natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
49. Latin America natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
50. Brazil natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
51. Brazil natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
52. Brazil natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
53. Rest of Latin America natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
54. Rest of Latin America natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
55. Rest of Latin America natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)
56. Middle  East & Africa natural killer cells therapeutics market revenue, by therapeutics, 2024-2032 (USD Billion)
57. Middle  East & Africa natural killer cells therapeutics market revenue, by application, 2024-2032 (USD Billion)
58. Middle  East & Africa natural killer cells therapeutics market revenue, by end user, 2024-2032 (USD Billion)